Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
about
Adjuvant radiotherapy following radical prostatectomy for prostate cancerRationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of FranceEvaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapyShared responsibility for treatment-related morbidity for prostate cancerOutcome of postoperative radiotherapy following radical prostatectomy: a single institutional experience.Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.Tools for consensus analysis of experts' contours for radiotherapy structure definitions.Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial.OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancerQuality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual OutcomesEvaluation and optimization of the parameters used in multiple-atlas-based segmentation of prostate cancers in radiation therapy.Preclinical Evaluation of Intraoperative Low-Energy Photon Radiotherapy Using Spherical Applicators in Locally Advanced Prostate CancerA Prostate Fossa Contouring Instructional Module: Implementation and Evaluation.Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.Postprostatectomy radiation therapy: an evidence-based review.Tools to analyse and display variations in anatomical delineation.Radiotherapy following radical prostatectomy.Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.Radiotherapy in the management of prostate cancer after radical prostatectomy.A survey of radiation treatment planning peer-review activities in a provincial radiation oncology programme: current practice and future directions.Evolution of hypofractionated accelerated radiotherapy for prostate cancer - the sunnybrook experience.Technology assessment of automated atlas based segmentation in prostate bed contouring.Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review.Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target Concept.Target volume definition for post prostatectomy radiotherapy: Do the consensus guidelines correctly define the inferior border of the CTV?ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT.Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes.Salvage radiation therapy following radical prostatectomy. A national Danish study.The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.Prostate bed motion during intensity-modulated radiotherapy treatment.Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.
P2860
Q24234347-3511FC1F-F65C-42E0-BEB9-4906BF5E2E34Q26774847-D5A2D696-3140-46FF-8067-A579EDD5B73FQ27690859-E5610F56-3E59-485C-83EF-6D6FB7FEAC8DQ28550852-F2702318-FDF1-4F73-AD4B-F6D25A7E293AQ30407539-8B141CD5-6031-44B9-8E85-4D76354F0CDEQ30413727-13C04F31-D611-4E58-B3A2-61A370188E31Q31083823-89D22BBA-3F7F-4411-974F-CD2C5D49B8F0Q33754017-4DE601A8-2AC4-437F-9FE2-10D05FE88CE5Q34325452-A6716E2E-4543-49AE-AE48-3B93880E28B7Q34725046-430AF7D3-BB50-4EDF-A405-952E84F01B79Q35017805-692EE4FF-E602-4982-AA38-B34F629D9D3DQ35048872-016EEBCD-F81A-4C40-BC0D-34694C931D24Q35685540-29997351-A0D1-48A3-AB85-887D463F6C6FQ35789050-846825E0-F216-4C54-B47C-3906C7C89305Q35825924-30372995-BF7F-47AA-A3F7-6A60A18498E0Q35833200-8757BFD2-4902-4A37-AE4D-7A7D134480F4Q36059956-84F9B840-1E04-468E-A984-16046E252411Q37072035-84FB8170-3635-48F3-B595-A5433A4E1582Q37201170-4B1768FF-C216-40AC-AA86-23D23DF72055Q37960204-64879923-8BEC-4494-AD48-ACDA6777CCBBQ38009749-29411E4B-970B-41F3-A9E8-012D63A3C097Q38030597-8892D986-BD2C-49A3-AE59-933B461F9D33Q38095669-7847101D-1BE2-4F08-B42D-FC72A05FE726Q38104412-82519186-9158-418D-AE7F-AA8D211BE854Q38125612-4A6D3C1D-11D2-4436-A3A8-A24197030601Q38276603-4936F295-0806-4450-9B95-E79E8CA8773DQ38563492-AEB513AA-5101-46E2-B94D-2AE8199C5238Q38575163-27232A5B-3F86-45E6-91DC-CD6871A997BEQ38633618-A59A0A2D-6EAF-4D8F-91CA-89A5A152D36BQ38705877-9909FB69-518E-4ACF-B588-673012355672Q38996907-4F3D89DB-7770-4BC8-B130-9D6E0E369323Q39197792-3A86E0A9-B2F2-4DDB-9DAD-1EAAF8F1800CQ39363908-F3AECC3D-D493-496B-8A13-941B0EC40D74Q39456200-7375DA8A-B0ED-434F-9F99-46E8FDA977D0Q40178727-59287FB9-A8AF-48F1-B1EF-571729BF4E60Q41148205-C7AFF4F7-F13B-4B6F-B504-34C8EF55BDD5Q41328641-A56A7714-C76D-4E03-890E-CF85C38DB022Q41435839-14747FC2-66DB-46F7-B23F-CE839CA50664Q41483713-0F1CC52C-DF87-4714-8EEF-02CE39BF2317Q41870659-2AEC5F0B-F5B0-4647-91CB-02545BEBB42B
P2860
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development of RTOG consensus ...... on therapy for prostate cancer
@ast
Development of RTOG consensus ...... on therapy for prostate cancer
@en
type
label
Development of RTOG consensus ...... on therapy for prostate cancer
@ast
Development of RTOG consensus ...... on therapy for prostate cancer
@en
prefLabel
Development of RTOG consensus ...... on therapy for prostate cancer
@ast
Development of RTOG consensus ...... on therapy for prostate cancer
@en
P2093
P2860
P1476
Development of RTOG consensus ...... on therapy for prostate cancer
@en
P2093
Anthony L Zietman
Charles Catton
Colleen Lawton
Cynthia Ménard
Elizabeth O'Meara
Howard Sandler
Issam El Naqa
Jeff M Michalski
Mark K Buyyounouski
Mark Ritter
P2860
P304
P356
10.1016/J.IJROBP.2009.02.006
P407
P577
2009-04-23T00:00:00Z